A University of South Australia-led research has found that regular consumption of a Mediterranean or Asian diet reduces the risk of prostate cancer diagnosis in
A new Australian bio-technology company secures a licence to develop a drug to block the development of metastatic prostate cancer. Filamon Limited, an Australian drug
Professor Hubert Hondermarck and his research team are identifying the key difference between aggressive prostate cancer tumours and less aggressive, indolent ones. It all comes
Researchers at Karolinska Karolinska Institute recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research
Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
